05:04 PM EDT, 03/27/2026 (MT Newswires) -- Helen Louise Collins, Chief Medical Officer, on March 25, 2026, sold 40,000 shares in Enliven Therapeutics ( ELVN ) for $1,404,024. Following the Form 4 filing with the SEC, Collins has control over a total of 25,000 common shares of the company, with 25,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1672619/000170124726000005/xslF345X05/form4-03272026_080317.xml